INSIGHTS ON DRUG DEVELOPMENT

• Softgel Formulation: Addressing Stability, Shelf-Life, And Bioavailability

  A CDMO that has expertise and resources in softgel formulation can help companies address stability issues, improve drug bioavailability, or ensure compliance with regulations.

• Accelerating mRNA Therapy Production With Digital Innovation

  Scaling mRNA therapies requires more than innovation—it demands precision. Discover how digital tools like automation and analytics are helping life science companies streamline production.

• White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges

  Explore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.

• Overcoming Excipient Risks And Challenges For Parenteral Formulations

  Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.

• Use Of Spray Drying In Pharmaceutical Product Development

  10/21/2024

  Through this detailed exploration, participants will gain valuable knowledge on how to leverage spray drying to optimize drug development and delivery.

• ADC Tech Talks Contract Manufacturing

  12/9/2024

  Experts share strategies to accelerate ADC development, including optimizing supply chains, seamless scale-up to GMP manufacturing, and leveraging process analytical technology.

• Why Reshoring Is An Essential Strategy For ADC Supply Chain Security

  2/24/2026

  Biotechs reshoring their supply chains to Western regions to mitigate risk and improve reliability require experienced partners to effectively manage these complex transitions.

• Thermofluor Screening For Injectable Protein Formulations

  9/15/2025

  The results herein highlight thermofluor screening as a versatile and efficient platform for rational formulation of injectable biologics through the acceleration of stable drug product development.

• Advancing Infectious Disease Research With This ddPCR System

  3/26/2026

  Efficient digital PCR workflows maximize data from 5µL samples. Achieve high-level multiplexing and faster turnaround times to accelerate discovery and verify NGS findings with total confidence.